Intelligent Control Approach to Anemia Management (AIM 4)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 2
- 主要终点
- Percent Hb 10-12 g/dL
研究概览
简要总结
First clinical evaluation of "Smart Anemia Manager" algorithm.
详细描述
The purpose of this single-center study is to test whether "Smart Anemia Manager" algorithm improves Hemoglobin stability compared to standard Anemia Management Protocol. Study site: Kidney Disease Program dialysis facility, University of Louisville, Louisville, KY.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Control
ESA Dose Adjustment per standard Anemia Management Protocol
干预措施: ESA Dose Adjustment per standard Anemia Management Protocol (Other)
Treatment
ESA Dose Adjustment per "Smart Anemia Manager" Algorithm
干预措施: ESA Dose Adjustment per "Smart Anemia Manager" Algorithm (Other)
结局指标
主要结局
Percent Hb 10-12 g/dL
时间窗: 12 months
Percentage of Hemoglobin concentrations measured (once per month) between 10 and 12 g/dL.
次要结局
- Percent Hb < 10 g/dL(12 months)
- ESA Dose(12 months)
- Percent Hb > 12 g/dL(12 months)
- Mean Hb(12 months)
研究者
Adam Edward Gaweda
Associate Professor
University of Louisville